Blood coagulation big three giants: Xisen Meikang, Sita Gao and Wolfen Competition
From the perspective of subdivision, immunity and biochemistry account for the largest proportion. Immunization is the largest market segment of IVD, and is also the main competitive market of the four giants ARDS; blood cells, urine, blood coagulation, microorganisms, etc. are the market segments that have developed rapidly and accounted for a significant increase in recent years. The biochemical and blood cell market is a field of full competition, and the profit rate is relatively low; the fields of immunity, blood coagulation, urine, microbes, etc. are mainly dominated by foreign-funded enterprises, and the profit rate is relatively high, which is also the focus of foreign companies in recent years. Input, the main force of domestic manufacturers.
Today, let's discuss the high-speed development of the blood coagulation market in the field of IVD in recent years. Welcome netizens to give pointers and make bricks for discussion.
Overview of the blood coagulation market
The blood coagulation market is a very fast-developing IVD segment in recent years, with a compound growth rate of 30% in recent years. In the past five years, the market share of the blood coagulation market in the rapidly developing IVD field has gradually increased from about 5% to about 10%.
At present, China's blood coagulation market has a capacity of about 2.7 billion yuan. Foreign-funded enterprises have absolute advantages in this field and are expected to occupy more than 90% of the market. Compared with the four giants of immune ARDS, blood coagulation is the three giants of WSS, namely the National Instruments Laboratory (IL, Werfen Group), the Japanese Sysmex Group (Sysmex Group), and the French Stagago (Stago Group). Other foreign-funded enterprises, such as Japan's Sekisui and Germany's BE, have a small share of the market. Domestic companies have a small market share, and Sekhid, Plymouth (Meiray Group members) and Shanghai Sun are among the best. Below we briefly introduce the main players in the market and the future direction.
Blood coagulation giant
Werfen
The National Instrumentation Laboratory (IL) was founded in 1959. In 1991, IL was wholly acquired by the Wolfen Group. Prior to 2012, Beckman Coulter was a global partner of the National Instruments Laboratory, the former responsible for the global promotion of IL blood coagulation products. Wolfen China was established in 2003 and will withdraw the business of IL blood coagulation products in China from Beckman after 2012. The advantage of IL blood coagulation lies in its very complete product line and extensive professional testing programs, with a broad customer base in the mid to high end markets in parts of the North. Over the past year or so, IL has taken the lead in introducing chemiluminescence analyzers and blood clotting line products for blood coagulation projects worldwide, and the industry has had a huge response.
Double Sided Nano Tape,Nano Double Sided Tape,Double Sided Magic Tape,Reusable Double Sided Tape
Kunshan Jieyudeng Intelligent Technology Co., Ltd. , https://www.yuhuanptapes.com